André Muller
Director of Finance/CFO chez IDORSIA LTD
Fortune : 297 359 $ au 31/03/2024
Profil
André C.
Muller is currently the Chairman at Chiron Investments AG.
He also holds current positions as an Independent Director at Carmat SA, Director & General Manager at Idorsia Pharmaceuticals Ltd., Director at Idorsia Pharmaceuticals US, Inc., and Director at Idorsia (Shanghai) Pharmaceuticals Co., Ltd.
In 2017, he started working as the Chief Financial Officer & Executive Vice President at Idorsia Ltd.
Previously, he worked as a Director at Nxera Pharma Japan Co., Ltd.
and as the Chief Financial Officer & Executive Vice President at Actelion Ltd.
from 2013 to 2017.
From 1994 to 2011, he served as the Chief Financial Officer at Pierre Fabre SA. Mr. Muller obtained an MBA from EM Lyon Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IDORSIA LTD.
0,05% | 31/12/2022 | 94 707 ( 0,05% ) | 297 359 $ | 31/03/2024 |
Postes actifs de André Muller
| Sociétés | Poste | Début |
|---|---|---|
| IDORSIA LTD | Director of Finance/CFO | 01/06/2017 |
| CARMAT | Director/Board Member | 01/01/2020 |
| Chiron Investments AG | Chairman | - |
| Idorsia Pharmaceuticals US, Inc. | Director/Board Member | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Director/Board Member | - |
| Idorsia (Shanghai) Pharmaceuticals Co., Ltd. | Director/Board Member | - |
Anciens postes connus de André Muller
| Sociétés | Poste | Fin |
|---|---|---|
| ACTELION | Director of Finance/CFO | 01/01/2017 |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Director of Finance/CFO | 01/01/2011 |
Idorsia Pharmaceuticals Japan Ltd.
 Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a private company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Director/Board Member | - |
Formation de André Muller
| EM Lyon Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CARMAT | Health Technology |
| IDORSIA LTD | Health Technology |
| Entreprise privées | 7 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Health Technology |
| Idorsia Pharmaceuticals US, Inc. | |
| Idorsia (Shanghai) Pharmaceuticals Co., Ltd. | |
Idorsia Pharmaceuticals Japan Ltd.
Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a private company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Health Technology |
| Chiron Investments AG |
